Cargando…
Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice
BACKGROUND: Previous studies have demonstrated that energy failure is closely associated with cardiac injury. Doxorubicin (DOX) is a commonly used clinical chemotherapy drug that can mediate cardiac injury through a variety of mechanisms. Thyroxine is well known to play a critical role in energy gen...
Autores principales: | Wang, Yuan, Zhu, Shan, Liu, Hongtao, Wei, Wen, Tu, Yi, Chen, Chuang, Song, Junlong, Li, Juanjuan, Sun, Shengrong, Wang, Changhua, Xu, Zhiliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935797/ https://www.ncbi.nlm.nih.gov/pubmed/31929843 http://dx.doi.org/10.1155/2019/7420196 |
Ejemplares similares
-
Interleukin-6 knockout reverses macrophage differentiation imbalance and alleviates cardiac dysfunction in aging mice
por: Wang, Yuan, et al.
Publicado: (2020) -
Thyroxine Affects Lipopolysaccharide-Induced Macrophage Differentiation and Myocardial Cell Apoptosis via the NF-κB p65 Pathway Both In Vitro and In Vivo
por: Zhu, Shan, et al.
Publicado: (2019) -
MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway
por: Li, Zhiyu, et al.
Publicado: (2021) -
TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling
por: Zhao, Ting, et al.
Publicado: (2021) -
LKB1-AMPK-mTOR信号传导通路在肿瘤中的研究进展
Publicado: (2011)